Trading

Data

Solutions

Insights

Complexa Stock

complexarx.comHealthcareFounded: 1900Funding to Date: $91.54MM

Complexa is a clinical stage biopharmaceutical company focused on transforming the treatment of fibrosis and inflammatory diseases.

Buy or sell Complexa stock Learn more about Complexa IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for Complexa.

Register Today

Team

Management Team

Meg Tarpey MD

Founding Scientist

Francisco Salva

Board Member, President & Chief Executive Officer

Bruce Freeman Ph.D

Co-Founder & Co-Founding Scientist

Theodore Danoff Ph.D

Chief Medical Officer

David Mott

Chairman of the Board of Directors

Joshua Tarnoff

Chief Executive Officer, President & Board Member

Raymond Miller JD

Co-Founder

Board Members

David Mott

Gilles Nobécourt

Andera Partners

Kenji Harada Ph.D

Jafco

Barbara Dalton Ph.D

Pfizer Ventures

I. Wistar Morris III

Sara Nayeem MD

New Enterprise Associates

Bernardus Machielse

Joshua Tarnoff

Other companies like Complexa in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$1.08B

Cytonics

Sector

Healthcare

Precision Neuroscience

Sector

Healthcare

News

Business Wire 08/19/2019

Complexa Names Theodore Danoff, MD, PhD, Chief Medical Officer

Complexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. Dr. Danoff formerly served as Chief Medica

Popular Topics

Popular Topics

Complexa Stock

Register for Details